XAIRのROE（自己資本利益率）は？

Beyond Air IncのROEは-542.75%です。

XAIRの配当利回りは？

Beyond Air Incの配当利回りは0.00%です。

XAIRの品質スコア（Quality Score）は？

当社のAIはXAIRの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

XAIRは今が買い時ですか？

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

XAIRはどのセクターに属しますか？

Beyond Air IncはHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）

XAIR (NASDAQ) 株価分析 | BEYOND AIR INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-05 | FS: 2026-03-31)

XAIR AI Analysis Summary

Our AI summary for XAIR: Beyond Air Inc (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -542.75%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

XAIR

Beyond Air Inc

US:NASDAQ STOCK Healthcare >> Medical Devices

USD 5.69

-0.49 (-7.93%) Day Change

Watchlist Portfolio Compare Chart

3.65

D/E

-542.8%

ROE

-94.0%

ROA

0.00%

Div Yield

BEYOND AIR INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 5.69 Price -0.49 (-7.93%) Day Change	NEWS SCORE: N/A

XAIR, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	5.69
PBV / Sector	0.38 / 4.62 GREAT
Earning Per Share	-80.11

PE / Sector	N/A / 32.46
PEG or PE/Growth / Sector	N/A / 0.50
Average 1M Daily Value	0.28 M GREAT
Average 1W Daily Value	0.70 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

43%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-432.99 / 20.56
NPM Average (%) / Sector	-25,373.14 / -15.33
NPM Change Average (%) / Sector	-78.63 / 6.80
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-93.96 / 11.32
ROA Average (%) / Sector	-109.00 / 0.03
ROA Change Average (%) / Sector	12.50 / 11.97 GOOD
ROE (%) / Sector	-542.75 / 43.37
ROE Average (%) / Sector	-314.83 / 25.05
ROE Change Average (%) / Sector	60.65 / 5.85 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.43
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 1.98

登録情報

Analyze Date	2026-08-06 08:00:55
Symbol	XAIR
Name	BEYOND AIR INC
Sector	Healthcare >> Medical Devices
Market	NASDAQ
Listed Shares	0.72 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	2.36 / 20,302.66

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 900 Stewart Avenue, Garden City, NY, United States, 11530

Phone: 516 665 8200

Website: https://www.beyondair.net

Employees: 54

Sector: Healthcare >> Medical Devices

Description: Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.